Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
SV Health Investors News
by
2w ago
..read more
Visit website
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium
SV Health Investors News
by
2w ago
..read more
Visit website
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
SV Health Investors News
by
2w ago
..read more
Visit website
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
SV Health Investors News
by
2w ago
..read more
Visit website
Harness Therapeutics appoints Leading World Experts in Neurodegenerative Diseases to its Scientific Advisory Board (SAB)
SV Health Investors News
by
2w ago
..read more
Visit website
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
SV Health Investors News
by
1M ago
..read more
Visit website
Transposon Receives US FDA Fast Track Designation for TPN-101 for Progressive Supranuclear Palsy
SV Health Investors News
by
1M ago
..read more
Visit website
The Sean M. Healey & AMG Center for ALS and Prilenia Therapeutics Announce First Participant Enrolled in NIH-Sponsored ACT for ALS Expanded Access Protocol for Pridopidine
SV Health Investors News
by
1M ago
..read more
Visit website
Cerevance Achieves First Milestone in Research Collaboration with MSD
SV Health Investors News
by
1M ago
..read more
Visit website
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases
SV Health Investors News
by
1M ago
..read more
Visit website

Follow SV Health Investors News on FeedSpot

Continue with Google
Continue with Apple
OR